Related references
Note: Only part of the references are listed.Update Systemic treatment of atopic dermatitis of the S2k-guideline on atopic dermatitis
Thomas Werfel et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2021)
Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis A Phase 3 Randomized Clinical Trial
Eric L. Simpson et al.
JAMA DERMATOLOGY (2020)
Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population
Zelma C. Chiesa Fuxench et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)
Dupilumab: A review of its use in the treatment of atopic dermatitis
Melinda J. Gooderham et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
E. L. Simpson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Guidelines of care for the management of atopic dermatitis
Robert Sidbury et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Management of Difficult-to-Treat Atopic Dermatitis
Peter D. Arkwright et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2013)
Epidemiology of Atopic Dermatitis and Atopic March in Children
Jonathan M. Spergel
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2010)
Share Paper
